Management of Respiratory Failure or ARDS In COVID Patients

Acute respiratory distress syndrome (ARDS) is one of the most serious complications associated with a higher risk of mortality in COVID-19 patients. It can originate from the vascular or gas side of the alveoli.

Although the site of entry or spread of COVID-19 is inhalational, alveolar infiltrates have been commonly found in the chest x-rays or computed tomography scans of patients with this infection. Respiratory distress also appears to include vascular damage that can potentially mandate a unique treatment approach other than what is recommended for patients who have developed ARDS due to other causes.

Also, a wide variation in the mortality rate has been observed across different intensive care units. This further raises the possibility that the differences in the approach to ventilatory management could be a factor contributing to the varying outcomes.

We are going to discuss this in detail in our ‘COVID19 PANDEMIC BY EXPERTS IN THE FIELD WEBINAR’ on 4th November.  Our webinar is focused on providing information about the latest developments in COVID-19 including the management of ARDS and short-term and long-term complications this infection can cause. You can join the webinar to keep yourself updated about the management of respiratory distress in COVID-19 patients.

Research studies have shown that the impact of COVID-19 is not limited to the lungs. It is a systemic disorder that can also injure the vascular endothelium. If not managed expertly and individually with consideration of its vasocentric features, it would not just increase the risk of ARDS but also lead to multiorgan failure, even in patients who are young or middle-aged without any pre-existing comorbidity.

Researchers have revealed that ARDS may also develop faster in COVID-19 patients due to the disproportionate endothelial damage that causes disruptions in the pulmonary vasoregulation, and ventilation-perfusion mismatch. This may lead to initial hypoxemia and foster thrombogenesis.

This might be in contrast to the pathogenesis of ARDS developed due to causes other than COVID-19. This marks the need to learn how respiratory distress needs to be managed differently and with a unique approach in COVID patients.

You can join the ‘COVID19 PANDEMIC BY EXPERTS IN THE FIELD WEBINAR’ on 4th November between 3 pm to 8 pm to learn more about the management of ARDS. We will discuss respiratory therapy CEU’s and why the approach needs to be modified in COVID-19 patients to improve the chances of positive outcomes.

We will also discuss the evolution and epidemiology of the COVID pandemic and how this infection can create havoc in the patient's body by creating complications.

We will share with you a clinician’s view from inside a COVID ICU to help physicians and nurses prepare themselves to face the challenges. This webinar also includes a discussion about the future of COVID-19 in view of treatments, vaccinations, and the development of herd immunity.

You will get an opportunity to interact with and ask questions to our panel of expert physicians. Join the respiratory conference to keep yourself updated about COVID-19 and improve your expertise in the management of this infection. 

Popular posts from this blog

What Is the Endocannabinoid System and What Is Its Role?

Image
  The endocannabinoid system (ECS) refers to a unique molecular system that is responsible for balancing and regulating several physiological processes in the body such as immune response, appetite, communication between cells, metabolism, and memory. Through this system, cannabinoids can interact with the metabolic enzymes and receptors in the body to trigger the therapeutic effects. In spite of the integral role played by the endocannabinoid system in our body, it was discovered only recently. The importance of the endocannabinoid system is also being understood by researchers and the medical community only in the past few decades. The ECS involves 3 basic components: endocannabinoids, enzymes, and receptors. Contrary to what most people believe, these 3 components of ECS are active in the body even when a person does not use cannabis or CBD oils. This marks why it is important to be aware of the role of ECS and the therapeutic benefits it offers to regulate the physiolog...
Read more

COVID-19 Pandemic Treatments, Vaccinations, And Herd Immunity

Image
COVID-19 Pandemic Treatments, Vaccinations, And Herd Immunit y   As the number of COVID-19 cases continues to rise across the world, everyone including patients, physicians, nurses, and healthcare workers are awaiting vaccines that might finally put an end to this challenging phase. There has also been a lot of discussion about herd immunity and how it would change the course of this pandemic. Most of us have our hopes pinned on herd immunity at least until vaccinations are made available. But what exactly is herd immunity and how it develops? Also, once we have it, will it really diminish the spread of this virus and reduce the need for social distancing and masks? These are the topmost questions in the minds of people. Let's find answers to what herb immunity actually means. What is herd immunity? Herd immunity is formed when enough patients have developed immunity to any specific infectious disease such that further community transmission is significantly reduced o...
Read more

Pulmonary Infectious Diseases

Image
  CLICK HERE TO JOIN ME Lung and airway infections are commonly referred to as pulmonary or respiratory infections. Chronic bronchitis, COPD, influenza, tuberculosis, and pneumonia are some of the major forms of respiratory infections.  Nasopharyngeal infections that result in nasal discharge, bronchitis that leads to cough and sputum, and pneumonia that leads to cough with sputum can also increase the respiratory rate and lead to breathing difficulties.  There are several viruses that contribute to the increased incidence of bronchitis, while bacteria are known to contribute to pneumonia.  These infections usually spread from infected patients to healthy people through contaminated droplets released into the air when the infected person sneezes and coughs. These respiratory conditions are the leading causes of mortality and morbidity from infectious diseases across the world. Nearly four million people are estimated to die due to acute respiratory infection every ye...
Read more